🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Chronic Hepatitis B Virus (Hbv)

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually Methylene Blue Treatment of Chronic Hepatitis B Virus Infection NCT06887036Phase 21 site📍 Lugano Fondazione Epatocentro Ticino · Tests: Methylene Blue SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus NCT06364930Phase 41 site📍 Hong Kong Chinese University of Hong Kong · Tests: Dapagliflozin 10mg Tab, Placebo 10mg Tab Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study） NCT06323681NA1 site📍 Shanghai Qing XIe · Tests: Peginterferon α-2b based treatment group, NAs monotherapy group Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) NCT03792919Phase 41 site📍 Hong Kong Humanity & Health Medical Group Limited · Tests: Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV neucleos(t)ides) Non-Invasive Model for Fibrosis Regression in HBV Patients NCT06874127n/a1 site📍 Beijing Beijing Friendship Hospital · Tests: Nucleos(t)ide Analogs (NA) Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF NCT03920618NA1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B NCT07606950Phase 31 site📍 Guangzhou Fujian Shengdi Pharmaceutical Co., Ltd. · Tests: HRS-5635 Injection, Placebo TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load. NCT05195450NA1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: Tenofovir alafenamide fumarate Evaluation of Patients With Liver Disease NCT00001971n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729) NCT06277037n/a18 sites📍 San Diego📍 Miami📍 Hillsborough Arbutus Biopharma Corporation · Tests: Non-interventional ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB) NCT07741461Phase 11 site📍 Shanghai Xiamen Amoytop Biotech Co., Ltd. · Tests: ACT201 Injection, ACT201 Injection Placebo Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B NCT04896255n/a1 site📍 Shanghai Huashan Hospital · Tests: peginterferon alpha based regimen, nucleos(t)ide Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance NCT07257562n/a1 site📍 Fuzhou First Affiliated Hospital of Fujian Medical University · Tests: PegIFNα2b+Nucleoside analog, PegIFNα2b+Nucleoside analog+Bacteroides fragilis+Branched-Chain Amino Acids Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B NCT03933384Phase 41 site📍 Taichung Taichung Veterans General Hospital · Tests: Tenofovir alafenamide, Entecavir TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852Phase 11 site📍 Baltimore University of Maryland, Baltimore · Tests: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B] Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection NCT07610772Phase 12 sites📍 Aarhus📍 Berlin Aarhus University Hospital · Tests: HepB mAb19 A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B NCT07389044Phase 15 sites📍 Hong Kong📍 Hong Kong📍 Chisinau IntegerBio · Tests: IB-001, Placebo, Peginterferon Alfa-2A Adaptability of an Undetectable = Untransmissible Model for HBV NCT07449091n/a1 site📍 New York NYU Langone Health Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B NCT06671093Phase 13 sites📍 Hong Kong📍 Chisinau📍 Auckland Tune Therapeutics, Inc. · Tests: Tune-401 Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA. NCT04231565NA1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: Tenofovir alafenamide Fumarate Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis NCT05905172Phase 323 sites📍 Beijing📍 Shanghai📍 Beijing Beijing Continent Pharmaceutical Co, Ltd. · Tests: Hydronidone capsules, The placebo capsules ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection NCT07573943Phase 41 site📍 Chongqing The Second Affiliated Hospital of Chongqing Medical Univers… · Tests: Anti-PD-L1 antibody (ASC22), Nucleotide analogs, Peg-IFNα Research on Clinical Recovery and Maintenance Strategies for CHB NCT06803368NA1 site📍 Beijing Beijing Municipal Administration of Hospitals · Tests: baseline anti-HBs titer A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B NCT07307586Phase 31 site📍 Zhengzhou Zhigang Ren · Tests: AZVUDINE, TAF, IFNα-2a Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION] NCT06216470Phase 21 site📍 Toronto University Health Network, Toronto · Tests: VIR-3434 Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study NCT07079150n/a2 sites📍 Xi'an📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: Peg IFN-α-2b Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B NCT07709520Phase 21 site📍 Beijing Fujian Akeylink Biotechnology Co., Ltd. · Tests: GST-HG141, GST-HG131, GST-HG141 Placebo Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure NCT07275554n/a1 site📍 Jinan Qilu Hospital of Shandong University From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients NCT06295328Phase 1, Phase 21 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Terbinafine, Placebo, Tenofovir
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy